How AI can slow the rise of antibiotic-resistant “superbugs”

Image courtesy of Cesar de la Fuente-Nunez

How AI can slow the rise of antibiotic-resistant “superbugs”

Loading...
References

Alsan, M., Atella, V., Bhattacharya, J., Conti, V.,  Mejía-Guevara, I., and Miller, G. 2019. “Reductions in Mortality Rates and Health Disparities with the Introduction of Penicillin,” Summary of working paper 25541. National Bureau of Economic Research. July 1. https://www.nber.org/bh-20192/reductions-mortality-rates-and-health-disparities-introduction-penicillin.

Cesaro, A., Hoffman, S.C., Das, P., and de la Fuente-Nunez, C. 2025. “Challenges and applications of artificial intelligence in infectious diseases and antimicrobial resistance.” NPT Antimicrobials and Resistance 3, no. 2. January 7. 0.1038/s44259-024-00068-x. https://www.nature.com/articles/s44259-024-00068-x#citeas

Santos-Júnior, C., Torres, M.D., Duan, Y., Huerta-Cepas, J., Schmidt, T.S., Chong, H.H., Fullam, A., et al. 2024. “Discovery of antimicrobial peptides in the global microbiome with machine learning.” Cell 187, no. 14. July 11: 3761-3778. 10.5281/zenodo.11055585. https://www.cell.com/cell/fulltext/S0092-8674(24)00522-1

GBD 2021 Antimicrobial Resistance Collaborators. 2024. “Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050.” The Lancet 404, no. 10459. September 28: 1199-1226. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)01867-1/fulltext

Maasch, J.R., Torres, M.D., Melo, M.C., and de la Fuente-Nunez, C. 2023. “Molecular de-extinction of ancient antimicrobial peptides enabled by machine learning.” Cell Host & Microbe 31, no. 8. August 9: 1260-1274. 10.1016/j.chom.2023.07.001. https://www.sciencedirect.com/science/article/pii/S1931312823002962

McKenna, M. 2011. Superbug: The Fatal Menace of MRSA. New York: Free Press.

Philo, S.E., De León, K.B., Noble, R.T., Zhou, N.A., Alghafri, R., Bar-Or, I., Darling, A., D’Souza, N., et al. 2023. “Wastewater surveillance for bacterial targets: current challenges and future goals.” Applied and Environmental Biology15, no. 90. December 15: 1428-23. 10.1128/aem.01428-23. https://pmc.ncbi.nlm.nih.gov/articles/PMC10807411/

Podolsky, S.H. 2006. Pneumonia before antibiotics: therapeutic evolution and evaluation in twentieth-century America.Baltimore: Johns Hopkins University Press.

Rex, John, and Damiano de Felice. 2025. “Italy delivers a national pull incentive.” AMR. Solutions. January 9. https://amr.solutions/2025/01/09/italy-delivers-a-national-pull-incentive-with-a-budget-of-eur-100-million-a-year/

Rhoads, J. 2014. “The Medical Context of Calvin Jr.’s Untimely Death.” Calvin Coolidge Presidential Foundation. July 7. https://coolidgefoundation.org/blog/the-medical-context-of-calvin-jr-s-untimely-death/.

Shapell, B., and Willen, S. 2017. “Calvin Coolidge Jr.’s Death.” Shapell Manuscripts Foundation. July 6. https://www.shapell.org/historical-perspectives/between-the-lines/death-calvin-coolidge-jr/.

Sweeney, C. 2021. “Artificial Intelligence’s Promise and Peril.” Harvard Public Health Magazine. September 29. https://harvardpublichealth.org/alumni-post/artificial-intelligences-promise-and-peril/

The Royal Family Channel. 2024. “Prince William Calls for Action To Create Better Access to Vaccines.” The Royal Family Channel. May 16. https://www.youtube.com/watch?v=qaMCPusxQGg

Thomas, D., and Wessel, C. 2022. “The State of Innovation in Antibacterial Therapeutics.” Biotechnology Innovation Organization. February 14. https://www.bio.org/sites/default/files/2022-02/The-State-of-Innovation-in-Antibacterial-Therapeutics.pdf

Torres, M.D., Cesaro, A. and de la Fuente-Nunez, C. “Peptides from non-immune proteins target infections through antimicrobial and immunomodulatory properties.” Trends Biotechnology. 2025 Jan; 43(1):184-205. 10.1016/j.tibtech.2024.09.008. https://www.cell.com/trends/biotechnology/fulltext/S0167-7799(24)00251-8

Torres, M.D., Brooks, E.F., Cesaro, A., Nicolaou, C., Bhatt, A.S., Sberro, H., Gill, M.O., and de la Fuente-Nunez, C. 2024. “Mining human microbiomes reveals an untapped source of peptide antibiotics.” Cell 187, no. 19. September 19: 5453-5467. 10.1016/j.cell.2024.07.027. https://www.cell.com/cell/fulltext/S0092-8674(24)00802-X

Torres, M.D., Melo, M.C., Flowers, L., Crescenzi, O., Notomista, E., and de la Fuente-Nunez, C. 2021. “Mining for encrypted peptide antibiotics in the human proteome.” Nature Biomedical Engineering 6. November 4: 67-75. https://www.nature.com/articles/s41551-021-00801-1

UK Parliament. 2024. “ ‘Netflix’ for antimicrobials: The Antimicrobial Products Subscription Model.” House of Commons Library. September 18. https://commonslibrary.parliament.uk/netflix-for-antimicrobials-the-antimicrobial-products-subscription-model/.

Wan, F., Torres, M.D., Peng, J., and de la Fuente-Nunez, C. 2024. “Deep-learning-enabled antibiotic discovery through molecular de-extinction.” Nature Biomedical Engineering 8. June: 854-871.10.1038/s41551-024-01201-x. June 11. https://www.nature.com/articles/s41551-024-01201-x

World Health Organization. 2023. “2023 Antibacterial agents in clinical and preclinical development: an overview and analysis.” June 14. https://www.who.int/publications/i/item/9789240094000

Together, we make the world safer.

The Bulletin elevates expert voices above the noise. But as an independent nonprofit organization, our operations depend on the support of readers like you. Help us continue to deliver quality journalism that holds leaders accountable. Your support of our work at any level is important. In return, we promise our coverage will be understandable, influential, vigilant, solution-oriented, and fair-minded. Together we can make a difference.


Get alerts about this thread
Notify of
guest

0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments

ALSO IN THIS ISSUE

RELATED POSTS